Lb Pharmaceuticals LBRX Insider Ownership

NASDAQ LBRX
$48.92 +1.40 (+2.94%)
As of: Sep 4, 2026 · 12:44 PM EDT

Insider Holdings by Owner

5.65Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
15.19%
0% pp QoQ
Shares Held by Insiders
882.24K
filed for Sep 2026
0.00% QoQ
Shares Outstanding
5.81Mn
5,806,862 shares
Direct Holdings
0
Indirect: 882.24K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
3
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of LBRX are Track Biotechnology Master Fund, Ltd. Deep (TenPercentOwner, 3.35Mn shares), Management 4 G.P. (2015) Ltd. Pontifax (TenPercentOwner, 1.41Mn shares), Management 4 G.P. (2015) Ltd. Pontifax (TenPercentOwner, 1.41Mn shares).

Form 4 Holdings

Insiders Holding LBRX

Insiders 3
Shares held 5.65Mn
Of outstanding 97.24%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Track Biotechnology Master Fund, Ltd. Deep TenPercentOwner 2,686,138 666,666 3,352,804 59.4% 16 Sep, 2025
2 Management 4 G.P. (2015) Ltd. Pontifax TenPercentOwner 0 1,411,681 1,411,681 25.0% 16 Sep, 2025
3 Ventures Gp Iii, L.L.C. Vida TenPercentOwner 0 882,243 882,243 15.6% 16 Sep, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

169 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
30 Jul, 2026 Track Biotechnology Master Fund, Ltd. Deep TenPercentOwner Acquired P 286,205 $34.94 $10.00Mn 664,649 Direct
03 Jun, 2026 Robert R Ruffolo Director Acquired A 10,000 $0.00 $0 10,000 Direct
03 Jun, 2026 William P Jr Kane Director Acquired A 10,000 $0.00 $0 10,000 Direct
03 Jun, 2026 J. Scott Garland Director Acquired A 10,000 $0.00 $0 10,000 Direct
03 Jun, 2026 Rebecca Luse Director Acquired A 10,000 $0.00 $0 10,000 Direct
03 Jun, 2026 Rekha Hemrajani Director Acquired A 10,000 $0.00 $0 10,000 Direct
06 Feb, 2026 Track Biotechnology Master Fund, Ltd. Deep TenPercentOwner Acquired P 378,444 $21.17 $8.01Mn 378,444 Direct
06 Feb, 2026 Track Biotechnology Master Fund, Ltd. Deep TenPercentOwner Acquired P 93,925 $21.17 $1.99Mn 93,925 Indirect
10 Dec, 2025 Panandiker Kaya Kamlesh Pai Chief Commercial Officer Acquired A 195,000 $0.00 $0 195,000 Direct
10 Dec, 2025 Panandiker Kaya Kamlesh Pai Chief Commercial Officer Acquired A 195,000 $0.00 $0 195,000 Direct
10 Dec, 2025 Panandiker Kaya Kamlesh Pai Chief Commercial Officer Acquired A 195,000 $0.00 $0 195,000 Direct
10 Dec, 2025 Panandiker Kaya Kamlesh Pai Chief Commercial Officer Acquired A 195,000 $0.00 $0 195,000 Direct
12 Sep, 2025 Management 4 G.P. (2015) Ltd. Pontifax TenPercentOwner Acquired C 411,681 411,681 Indirect
12 Sep, 2025 Management 4 G.P. (2015) Ltd. Pontifax TenPercentOwner Acquired C 411,681 411,681 Indirect
12 Sep, 2025 Ventures Gp Iii, L.L.C. Vida TenPercentOwner Acquired C 547,648 547,648 Indirect
12 Sep, 2025 Ventures Gp Iii, L.L.C. Vida TenPercentOwner Acquired C 547,648 547,648 Indirect
12 Sep, 2025 Management 4 G.P. (2015) Ltd. Pontifax TenPercentOwner Acquired C 411,681 411,681 Indirect
12 Sep, 2025 Management 4 G.P. (2015) Ltd. Pontifax TenPercentOwner Acquired C 411,681 411,681 Indirect
12 Sep, 2025 Track Biotechnology Master Fund, Ltd. Deep TenPercentOwner Acquired C 686,138 686,138 Direct
12 Sep, 2025 Ventures Gp Iii, L.L.C. Vida TenPercentOwner Acquired C 547,648 547,648 Indirect